Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration.

Dember LM, Lacson E Jr, Brunelli SM, Hsu JY, Cheung AK, Daugirdas JT, Greene T, Kovesdy CP, Miskulin DC, Thadhani RI, Winkelmayer WC, Ellenberg SS, Cifelli D, Madigan R, Young A, Angeletti M, Wingard RL, Kahn C, Nissenson AR, Maddux FW, Abbott KC, Landis JR.

J Am Soc Nephrol. 2019 May;30(5):890-903. doi: 10.1681/ASN.2018090945. Epub 2019 Apr 18.

PMID:
31000566
2.

Blood Microbiome Profile in CKD : A Pilot Study.

Shah NB, Allegretti AS, Nigwekar SU, Kalim S, Zhao S, Lelouvier B, Servant F, Serena G, Thadhani RI, Raj DS, Fasano A.

Clin J Am Soc Nephrol. 2019 May 7;14(5):692-701. doi: 10.2215/CJN.12161018. Epub 2019 Apr 8.

PMID:
30962186
3.

Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: Results from the Progredir Cohort.

Titan SM, Venturini G, Padilha K, Goulart AC, Lotufo PA, Bensenor IJ, Krieger JE, Thadhani RI, Rhee EP, Pereira AC.

PLoS One. 2019 Mar 18;14(3):e0213764. doi: 10.1371/journal.pone.0213764. eCollection 2019.

4.

Aiming Too Low: Reevaluation of Target Concentrations of Serum 25-Hydroxyvitamin D in Secondary Hyperparathyroidism.

Berg AH, Thadhani RI.

Am J Nephrol. 2019;49(4):281-283. doi: 10.1159/000499160. Epub 2019 Mar 15. No abstract available.

5.

1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics.

Tavares G, Venturini G, Padilha K, Zatz R, Pereira AC, Thadhani RI, Rhee EP, Titan SMO.

Metabolomics. 2018 Feb 27;14(4):39. doi: 10.1007/s11306-018-1337-9.

PMID:
30830377
6.

Cardiovascular Outcomes in African Americans with Sickle Cell Trait and Chronic Kidney Disease.

Olaniran KO, Eneanya ND, Allegretti AS, Zhao SH, Achebe MM, Thadhani RI.

Am J Nephrol. 2019;49(2):93-102. doi: 10.1159/000496058. Epub 2019 Jan 9.

PMID:
30625463
7.

Predicting the Future Is Not Difficult.

Cerdeira AS, Thadhani RI.

Hypertension. 2019 Jan;73(1):47-48. doi: 10.1161/HYPERTENSIONAHA.118.11931. No abstract available.

PMID:
30571566
8.

Sickle Cell Nephropathy in the Pediatric Population.

Olaniran KO, Eneanya ND, Nigwekar SU, Vela-Parada XF, Achebe MM, Sharma A, Thadhani RI.

Blood Purif. 2019;47(1-3):205-213. doi: 10.1159/000494581. Epub 2018 Dec 5. Review.

9.

Complement 7 Is Up-Regulated in Human Early Diabetic Kidney Disease.

Sircar M, Rosales IA, Selig MK, Xu D, Zsengeller ZK, Stillman IE, Libermann TA, Karumanchi SA, Thadhani RI.

Am J Pathol. 2018 Oct;188(10):2147-2154. doi: 10.1016/j.ajpath.2018.06.018.

PMID:
30253844
10.

Angiogenic biomarkers in triage and risk for preeclampsia with severe features.

Rana S, Salahuddin S, Mueller A, Berg AH, Thadhani RI, Karumanchi SA.

Pregnancy Hypertens. 2018 Jul;13:100-106. doi: 10.1016/j.preghy.2018.05.008. Epub 2018 May 25.

PMID:
30177034
11.

Metabolites related to eGFR: Evaluation of candidate molecules for GFR estimation using untargeted metabolomics.

Titan SM, Venturini G, Padilha K, Tavares G, Zatz R, Bensenor I, Lotufo PA, Rhee EP, Thadhani RI, Pereira AC.

Clin Chim Acta. 2019 Feb;489:242-248. doi: 10.1016/j.cca.2018.08.037. Epub 2018 Aug 25.

PMID:
30153452
12.

Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis.

Allegretti AS, Vela Parada X, Ortiz GA, Long J, Krinsky S, Zhao S, Fuchs BC, Sojoodi M, Zhang D, Karumanchi SA, Kalim S, Nigwekar SU, Thadhani RI, Parikh SM, Chung RT.

Hepatology. 2019 Feb;69(2):729-741. doi: 10.1002/hep.30230. Epub 2019 Jan 4.

PMID:
30141205
13.

De novo NAD+ biosynthetic impairment in acute kidney injury in humans.

Poyan Mehr A, Tran MT, Ralto KM, Leaf DE, Washco V, Messmer J, Lerner A, Kher A, Kim SH, Khoury CC, Herzig SJ, Trovato ME, Simon-Tillaux N, Lynch MR, Thadhani RI, Clish CB, Khabbaz KR, Rhee EP, Waikar SS, Berg AH, Parikh SM.

Nat Med. 2018 Sep;24(9):1351-1359. doi: 10.1038/s41591-018-0138-z. Epub 2018 Aug 20.

14.

Calciphylaxis in Patients With Normal Renal Function: A Case Series and Systematic Review.

Bajaj R, Courbebaisse M, Kroshinsky D, Thadhani RI, Nigwekar SU.

Mayo Clin Proc. 2018 Sep;93(9):1202-1212. doi: 10.1016/j.mayocp.2018.06.001. Epub 2018 Jul 27.

PMID:
30060958
15.

Association of Smoking Status With Mortality and Hospitalization in Hemodialysis Patients.

Li NC, Thadhani RI, Reviriego-Mendoza M, Larkin JW, Maddux FW, Ofsthun NJ.

Am J Kidney Dis. 2018 Nov;72(5):673-681. doi: 10.1053/j.ajkd.2018.04.004. Epub 2018 Jun 15.

PMID:
29909936
16.

The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study.

Srivastava A, Palsson R, Kaze AD, Chen ME, Palacios P, Sabbisetti V, Betensky RA, Steinman TI, Thadhani RI, McMahon GM, Stillman IE, Rennke HG, Waikar SS.

J Am Soc Nephrol. 2018 Aug;29(8):2213-2224. doi: 10.1681/ASN.2017121260. Epub 2018 Jun 4.

PMID:
29866798
17.

Epidemiology: Chronic disease, cancer, and exercise - a common link.

Allegretti AS, Thadhani RI.

Nat Rev Nephrol. 2018 May;14(5):288-290. doi: 10.1038/nrneph.2018.24. Epub 2018 Mar 26. No abstract available.

PMID:
29578209
18.

Acute Homeostatic Changes Following Vitamin D2 Supplementation.

Berg AH, Bhan I, Powe C, Karumanchi SA, Xu D, Thadhani RI.

J Endocr Soc. 2017 Jul 19;1(9):1135-1149. doi: 10.1210/js.2017-00244. eCollection 2017 Sep 1.

19.

Increased Bone Morphogenetic Protein Signaling in the Cutaneous Vasculature of Patients with Calciphylaxis.

Nigwekar SU, Jiramongkolchai P, Wunderer F, Bloch E, Ichinose R, Nazarian RM, Thadhani RI, Malhotra R, Bloch DB.

Am J Nephrol. 2017;46(5):429-438. doi: 10.1159/000484418. Epub 2017 Nov 9.

20.

Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT.

Allegretti AS, Parada XV, Eneanya ND, Gilligan H, Xu D, Zhao S, Dienstag JL, Chung RT, Thadhani RI.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):16-25. doi: 10.2215/CJN.03610417. Epub 2017 Nov 9.

Supplemental Content

Loading ...
Support Center